FDA commissioner search slowed by tobacco settlement proposal.
This article was originally published in The Tan Sheet
Executive Summary
FDA COMMISSIONER SEARCH SLOWED BY TOBACCO SETTLEMENT PROPOSAL as the Clinton Administration needs time to consider the change in political landscape for FDA. Following the departure of David Kessler, MD, in February, the Administration appeared to be hoping to finesse the tobacco issue by choosing a candidate who would be less openly antagonistic to the tobacco industry. The conclusion of settlement negotiations, however, has brought the issue of FDA's role in the regulation of cigarettes back to prominence, ensuring that tobacco potentially could be the sole focus of Capitol Hill discussions of a commissioner nominee.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning